0001209191-19-025373.txt : 20190419
0001209191-19-025373.hdr.sgml : 20190419
20190419161347
ACCESSION NUMBER: 0001209191-19-025373
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190417
FILED AS OF DATE: 20190419
DATE AS OF CHANGE: 20190419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wolchko J Scott
CENTRAL INDEX KEY: 0001586893
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36076
FILM NUMBER: 19758064
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3535 GENERAL ATOMICS COURT
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 3535 GENERAL ATOMICS COURT
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-17
0
0001434316
FATE THERAPEUTICS INC
FATE
0001586893
Wolchko J Scott
C/O FATE THERAPEUTICS, INC.;
3535 GENERAL ATOMICS COURT #200
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
Common Stock
2019-04-17
4
M
0
1092
1.63
A
375973
D
Common Stock
2019-04-17
4
S
0
1092
16.1062
D
374881
D
Common Stock
2019-04-17
4
M
0
7449
1.63
A
382330
D
Common Stock
2019-04-17
4
S
0
7449
16.1826
D
374881
D
Common Stock
2019-04-18
4
M
0
6843
1.63
A
381724
D
Common Stock
2019-04-18
4
S
0
6843
16.014
D
374881
D
Common Stock
2019-04-18
4
M
0
4616
1.63
A
379497
D
Common Stock
2019-04-18
4
S
0
4616
16.015
D
374881
D
Stock Option (right to buy)
1.63
2019-04-17
4
M
0
1092
D
2022-02-08
Common Stock
1092
6843
D
Stock Option (right to buy)
1.63
2019-04-17
4
M
0
7449
D
2022-02-08
Common Stock
7449
18951
D
Stock Option (right to buy)
1.63
2019-04-18
4
M
0
6843
D
2022-02-08
Common Stock
6843
0
D
Stock Option (right to buy)
1.63
2019-04-18
4
M
0
4616
D
2022-02-08
Common Stock
4616
14335
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018.
Represents the weighted average sale price of the shares sold ranging from $16.00 to $16.73 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Represents the weighted average sale price of the shares sold ranging from $16.00 to $16.84 per share. The Reporting person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Represents the weighted average sale price of the shares sold ranging from $16.00 to $16.04 per share. The Reporting person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
The shares subject to this option became fully vested and exercisable on May 30, 2015.
Not applicable.
The shares subject to this option became fully vested and exercisable on October 4, 2015.
/s/ Cindy R. Tahl, as Attorney-in-Fact
2019-04-19